Skip to main content
PCVX logo

PCVX · Vaxcyte, Inc. · Executive Compensation

Track PCVX — free
$60.16 +1.64 (+2.80%) Play latest call Q4 2025 earnings call transcript
Market Cap
$9.26B
Shares
158.30M
Volume · Nov 19 172.87K Avg daily vol (3M) 2.16M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Grant Pickering $14,458,937
Andrew Guggenhime $6,072,939
Jim Wassil $5,809,971
Mikhail Eydelman $4,005,935
Harp Dhaliwal $3,764,679
Fiscal 2024
Executive Total
Grant Pickering $39,639,512
Andrew Guggenhime $17,878,117
Jim Wassil $17,867,617
Mikhail Eydelman $5,663,443
Fiscal 2023
Executive Total
Grant Pickering $12,135,684
Andrew Guggenhime $5,415,277
Jim Wassil $5,401,215
Mikhail Eydelman $3,492,348
Fiscal 2022
Executive Total
Grant Pickering $13,661,941
Jim Wassil $6,991,203
Andrew Guggenhime $6,902,093
Mikhail Eydelman $5,013,144
Paul Sauer $2,354,242
Fiscal 2021
Executive Total
Grant Pickering $5,291,474
Andrew Guggenhime $2,753,001
Jim Wassil $1,970,336
Paul Sauer $1,087,630
Mikhail Eydelman —
Fiscal 2020
Executive Total
Andrew Guggenhime $5,650,072
Grant Pickering $3,374,620
Jim Wassil $1,357,549
Paul Sauer $904,518
Mikhail Eydelman —

Executive changes

Person Change Filed
David McAvoy Appointed 2026-09-03
John Markels Appointed 2026-07-15
Heath Lukatch
“Dr. Lukatch’s retirement was not the result of any disagreement or dispute with the Company.”
Retired 2026-07-15
Moncef Slaoui Appointed 2026-06-23
Jacks Lee
“Mr. Lee’s retirement was not the result of any disagreement or dispute with the Company.”
Retired 2026-06-23
Dr. Olivier Brandicourt Appointed 2025-05-01
John P. Furey Appointed 2024-07-02
Jacks Lee Appointed 2023-11-28
Elvia Cowan Appointed 2022-12-12
Carlos V. Paya, M.D., Ph.D. Appointed 2021-10-28
Michael Kamarck, Ph.D. Appointed 2021-10-28
Carlos V. Paya, M.D., Ph.D. Appointed 2021-10-28
Annie Drapeau Appointed 2021-09-20
Teri Loxam Appointed 2021-09-20
Rob Hopfner Resigned 2021-09-20
Patrick Heron Resigned 2021-09-20

Leadership

Key facts CIK 1649094 CUSIP 92243G108 13F (30d) 372 filings 338 filers Visit website Investor relations